Note: This medical device record is a PMA supplement. A supplement may have changed the device description/function or indication from that approved in the original PMA. Be sure to look at the original PMA record for more information. |
|
Device | HYBRID CAPTURE 2 HIGH-RISK HPV DNA TEST AND HYBRID CAPTURE HPV DNA TEST |
Generic Name | KIT, DNA DETECTION, HUMAN PAPILLOMAVIRUS |
Applicant | QIAGEN GAITHERSBURG, INC 19300 Germantown Road Germantown, MD 20874 |
PMA Number | P890064 |
Supplement Number | S013 |
Date Received | 10/01/2003 |
Decision Date | 11/07/2003 |
Product Code |
MAQ |
Advisory Committee |
Microbiology |
Supplement Type | Real-Time Process |
Supplement Reason | Labeling Change - Indications/instructions/shelf life/tradename |
Expedited Review Granted? | No |
Combination Product | No |
Approval Order Statement APPROVAL FOR: 1) MODIFICATION OF HYBRIDIZATION PROCEDURAL STEPS AND SEQUENCE; THIS MODIFICATION ENTAILS REVERSING THE ADDITION ORDER OF THE HPV RNA PROBES AND DENATURED SPECIMEN WITH NO CHANGE IN PROBE OR SPECIMEN VOLUME. AN ADDITIONAL 10 MINUTE INCUBATION PERIOD AT ROOM TEMPERATURE (15 DEGREES C TO 30 DEGREES C) WAS ADDED AFTER REMOVAL OF THE SPECIMEN FROM THE 65 += 2 DEGREES C, 60 MINUTES HYBRIDIZATION INCUBATION STEP. 2) ADDITION OF AN EQUIVOCAL RESULT ZONE, WHICH REQUIRES REPEATING SPECIMENS THAT HAVE RESULTS WITHIN THIS RESULT ZONE, FOR SPECIMENS COLLECTED IN PRESERVCYT TRANSPORT MEDIUM. THIS EQUIVOCAL RESULT ZONE HAS BEEN ESTABLISHED TO BE >=1.0 AND <+ 2.5 RLU/CO. 3)_ REMOVAL OF THE EQUIVOCAL RESULT ZONE FROM SPECIMENS COLLECTED IN THE DIGENE SPECIMEN TRANSPORT MEDIUM. |
|
|